GlassScriptPhysician profile
Jonathan Edward Heinlen
NPI 1275739856
$5,096.97
in general payments reported to CMS, 2019-2025
21 companies · $69.83 in 2025
The $69.83 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,144 · 2020: $2,845 · 2021: $267 · 2022: $156 · 2023: $397 · 2024: $218 · 2025: $69.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.89 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,577.14 | 2020 | |
| Stryker Corporation | $464.22 | 2019 | |
| Urogen Pharma, INC. | $286.28 | 2021-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $255.78 | 2019-2022 | |
| Coloplast Corp | $237.01 | 2019-2024 | Speedicath |
| Astellas Pharma Global Development | $201.84 | 2022-2023 | Xtandi |
| Intuitive Surgical, INC. | $161.29 | 2020 | |
| Biotissue Holdings INC. | $125.47 | 2024 | |
| Osiris Therapeutics INC. | $119.63 | 2019 | |
| Procept Biorobotics Corporation | $117.17 | 2019 | |
| Clarus Therapeutics INC. | $106.42 | 2020 | |
| Astellas Pharma US INC | $88.06 | 2019-2023 | Xtandi, Padcev |
| Astrazeneca Pharmaceuticals LP | $86.99 | 2023 | Lynparza |
| Boston Scientific Corporation | $84.71 | 2023-2024 | Rezum Generator, Ams 700 |
| Teleflex LLC | $54.82 | 2025 | Barrigel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $40.52 | 2022 | |
| Acera Surgical, INC. | $30.81 | 2023 | Restrata Wound Matrix |
| Pfizer INC. | $20.57 | 2023 | |
| Cook Medical LLC | $14.22 | 2019 | |
| Bard Access Systems, INC. | $12.58 | 2019 | |
| Medtronic USA, INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Heinlen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.